Completed Clinical Trials

Immunotoxin Therapy in Treating Patients With Advanced Cancer

By April 24, 2017 No Comments


Cervical Cancer|Fallopian Tube Cancer|Head and Neck Cancer|Lung Cancer|Malignant Mesothelioma|Ovarian Cancer|Pancreatic Cancer|Primary Peritoneal Cavity Cancer

Estimated Enrollment: null

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: CDR0000068351|NCI-01-C-0011|NCI-6249

Study First Received: December 6, 2000

Last Updated: April 29, 2015

Estimated Primary Completion Date: null


Primary Outcome Measures:

Sponsors and Collaborators:

National Cancer Institute (NCI)

Website Link:

Leave a Reply

Call Now